Connect with us

Headlines of The Day

BioAsia 2024 to ignite entrepreneurship, promote startups

BioAsia 2024, Asia’s largest life-sciences and healthcare conference, is set to ignite innovation and entrepreneurship with its amplified focus on Startup showcase.

With the theme ‘Data & AI: Redefining Possibilities’ BioAsia 2024 which is set to take place from February 26 to 28 in Hyderabad, hosted by the government of Telangana, is poised to transform the entrepreneurial journey for startups within the healthcare and life sciences sectors.

The ‘Innovation Zone’ at BioAsia 2024 will be a dynamic hub showcasing the Startup Stage Pavilion and the Incubator Pavilion, igniting innovation, and unlocking investment opportunities. In line with BioAsia’s ethos of fostering innovation, a select group of about 70 startups have earned coveted spots in the 21st edition of this global conference to showcase their innovative solutions that have potential to transform healthcare globally.

These startups will benefit from participation fee waivers and complimentary display booths, providing them with a prestigious platform to present their ground-breaking concepts.

In a unique and unparalleled opportunity, selected startups not only gain access to complimentary exhibition space but also unlock the doors to exclusive interactions with industry titans such as Mr.David Ricks, CEO of Eli Lilly, Mr. Chris Boerner, CEO of Bristol Myers Squibb, and other influential Global Leaders.

The response from industries to attend BioAsia 2024 has been overwhelming, with numerous companies eagerly lining up to participate. The event has attracted interest from both national and international corporations, indicating a strong desire to engage with the latest innovations and developments in the life sciences and healthcare sectors.

The line-up of startups set to grace BioAsia 2024 spans a diverse spectrum, from medical technology startups revolutionizing Drug Discovery Platforms to medical device startups solving for cancer screening, nasal septum, limb movements.

Additionally, biotechnology startups are making strides in areas such as small molecule nanoparticles and novel drug candidates.

Telangana Minister for IT and Industries D Sridhar Babu, said “We are thrilled by the overwhelming response from industries to participate in BioAsia 2024, demonstrating the event’s pivotal role in fostering innovation and collaboration within the life sciences and healthcare sectors. This enthusiasm extends to the start-up ecosystem, where promising ventures eagerly anticipate showcasing their ground-breaking solutions to a global audience”.

As we witness enthusiastic engagement from both national and international companies, it reaffirms our commitment to positioning Telangana as a global leader in the field, empowering start-ups to thrive and innovate on a world stage, the Minister added.

Telangana Principal Secretary of the Industries & Commerce (I&C) and Information Technology (IT) Departments Jayesh Ranjan, said ‘ As AI continues to permeate the life sciences sector, there is a growing interest among stakeholders to leverage its potential for accelerating research and development in healthcare.

To fuel this momentum, Incubator Pavilion and Innovation Zone will be aimed at fostering innovation and business growth through the application of data and AI in healthcare and life sciences’.

Telangana Life sciences Director Shakthi Nagappan said ‘With this year’s theme centered around the Data and AI revolution, BioAsia 2024 presents an unparalleled opportunity to forge partnerships and drive impactful collaborations’.

A panel of seasoned experts representing both industries and academia have shortlisted around 70 start-ups for exhibiting at the venue. Among these, the top 5 standouts will have the exceptional honour of presenting their groundbreaking ideas during BioAsia’s Valedictory session, he added.

Over three days, industry stalwarts, distinguished scientists, researchers, and entrepreneurs will converge to explore the potential of reshaping the future of healthcare delivery in the country. United News of India

Copyright © 2024 Medical Buyer

error: Content is protected !!